In analogy to known oncofetal tumor markers, such as AFP and Gpc-3, Marquardt et al. [104] established Nope as a new and promising oncofetal surface marker for murine and human HCC and provided evidence for its specific expression in hepatoma cell lines and primary HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.